Treatment of clinically severe bovine mastitis - a scoping review.

Mastitis is a major health problem for bovines and can be categorized as non-severe or severe, based on clinical symptoms. A severe case of clinical mastitis is usually defined by the cow being affected systemically. It is important to consider how to handle severe cases because these cases can be fatal and cause high production losses. However, there are generally few detailed treatment guidelines. By conducting a scoping review on the topic, we aimed to synthesize the information that is available on treatment and outcomes, as reported from clinical trials and observational studies. This was facilitated by following the PRISMA-guidelines with a stepwise systematic screening of scientific literature on the subject, retrieved via Pubmed and Web of Science, using pre-defined selection criteria. The results yielded a total of 14 reports of treatment and outcomes in cases of naturally occurring severe clinical mastitis. Cross-trial comparison was difficult due to the different exclusion criteria and outcome definitions. Many studies focused on cases caused by gram-negative bacteria treated with intensive antibiotic protocols, often containing antibiotics that are categorized as critical for human health. Few focused on severe cases caused by gram-positive bacteria or on the relative use of non-antibiotic treatment. In general, only a small number of statistically significant differences were found in trials comparing different treatment protocols, with no obvious trends across trials. Our findings emphasize the need for more research into the treatment efficacy of antibiotic and non-antibiotic options for clinically severe mastitis. Furthermore, consideration of how trial conditions relate to the practical circumstances in a field setting could improve the applicability of reported results. This could help to provide practitioners with the information needed to make evidence-based treatment decisions in cases of clinically severe mastitis.

Lactational treatment of bovine mastitis-Development over time and factors influencing cytological cure.

Lactational treatment of bovine mastitis is a major contributor to antibiotic consumption in dairy cattle and is, therefore, important to address in light of the increasing problem of antibiotic resistance. In this large-scale database-based retrospective observational study, we combined electronic health records and routinely measured somatic cell counts from individual cows to create an overview of lactational mastitis treatment in Danish dairy herds from 2010 to 2019. Furthermore, posttreatment somatic cell count was used to approximate treatment success in terms of cytological cure. A generalized logistic regression with mixed effects was performed to combine knowledge on cow-level factors (treatment-, pathogen-, and cow-related) with the new infection risk at the herd level, and to explore the relative effect on cytological cure. The investigation revealed that the total number of lactational treatments appears to have decreased steadily over the study period, whereas treatment duration increased slightly. The proportion of cases treated with penicillin-based protocols and the proportion of milk samples sent for pathogen analysis also decreased. Meanwhile, results from the statistical analysis confirm the importance of cow-related factors, such as parity and lactation stage, for the probability of cytological cure following lactational treatment of mastitis. However, they also disclose that factors that are easier to adjust, such as optimizing treatment duration, including knowledge on causative pathogens and improving the herd-level new infection risk that can be used to positively influence the outcome. Application of this knowledge could potentially assist in promoting a more prudent use of antibiotics for dairy cattle in the future.

Veterinary Treatment Approach and Antibiotic Usage for Clinical Mastitis in Danish Dairy Herds.

Danish veterinarians' treatment approach and use of antibiotics for clinical mastitis were investigated through a web-based questionnaire. The objective of the study was to describe and evaluate how the clinical mastitis treatment practice in Danish dairy herds corresponds to evidence from the literature and legislative requirements, in order to suggest directions for improvements and approaches encouraging the prudent use of antibiotics. In total, 174 veterinarians working with cattle received the questionnaire and 85 (48.9%) completed it. Their answers suggested that the Danish treatment approach for clinical mastitis generally relies on combined systemic and intramammary antibiotic administration (92% would use this often or always) and almost always includes supportive treatment with nonsteroidal anti-inflammatory drugs (99% would use it often or always in combination with antibiotic therapy). While collecting milk samples in order to target treatment towards pathogens is a priority in the legislation and for veterinarians, the direct application seems hindered due to the waiting time with the currently used analysis practice. Consequently, 91% reported that they would start treatment immediately after clinical examination often or always. The results of this investigation show that there is a potential for improvement in targeting treatments towards the causative pathogen by encouraging methods that allow for a more rapid reliable pathogen determination. When this issue has been addressed, the available evidence on the best treatment practice of Gram-negative-caused mastitis cases can be applied properly, reducing the volume of antibiotic treatments with limited expected effect. Additionally, investigating the potential of reducing combined administration to only intramammary treatment in Gram-positive cases could be a further step towards a more prudent antibiotic strategy.

Technical note: Serum total protein and immunoglobulin G concentrations in neonatal dairy calves over the first 10 days of age.

Efficacy of passive transfer of immunity in young calves is commonly assessed using total serum protein (STP) or serum immunoglobulin G (IgG) concentration tested within the first few days of life. To our knowledge, no research has measured changes in these concentrations over this period to establish an appropriate age range for testing. The aim of this study was to monitor changes in STP and serum IgG concentrations from birth until 10 d of age to provide a basis for recommendations for when passive transfer of immunity in dairy calves can be measured. Concentrations of STP and IgG of 12 calves were measured at 11 time points: at approximately 30 min before colostrum feeding, at 24 h after colostrum feeding, and daily from d 2 to 10 of age. Mean (± standard deviation) STP and IgG concentrations were 4.61 ± 0.3 g/dL and 0.6 ± 0.6 mg/mL at birth, 5.83 ± 0.73 g/dL and 22.2 ± 9.6 mg/mL at 24 h after colostrum feeding, and 5.78 ± 0.52 g/dL and 16.1 ± 7.3 mg/mL at d 10 of age, respectively. The IgG concentration declined over subsequent days relative to IgG measured at 24 h at a rate of approximately 0.69 mg/mL per day, declining by 27.6 ± 6.2% (mean ± SD) on d 10. The concentration of STP did not decrease over time. Concentrations of IgG at 24 h after colostrum feeding were highly correlated with each of the measures of IgG over the 10-d period (r ≥0.97). These correlations were supported by the Bland-Altman plots of agreement between the 24-h sample and subsequent samples. Compared with the reference value at 24 h, STP concentrations were highly correlated on d 2 and 3 (r ≥0.98), highly correlated but variable from d 4 to 9 (r ≥0.88), and lower at d 10 (r = 0.76). These results indicate that calves may be reliably tested for passive transfer of immunity using IgG or STP concentrations up to 9 d of age.